ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

Why Pembrolizumab is on this study

  • The record lists it as a treatment.
  • Claude Opus 5.5 judged it not given in this study. Nov 1, 2026, 9:28 AM UTC“Earlier treatment, not given in this study”
  • The role rule had no answer: no treatment entry names it.
  • So Pembrolizumab's page does not count this study.
4 links0 made here, not in the record5 judgments2 judges (the rules as one: Rule based)0 record changes seen
Claude Opus 5.5Rule basedReplaced, or read an older version
Oct 19Oct 26Nov 2Nov 9Nov 16Nov 23TodayNCT06856213Study of CetuximabPlus/Minus WeeklyPaclitaxel AfterProgression To First-LinePembrolizumab PlusPlatinum-5FU in SubjectsWith Recurrent/MetastaticGrupo Español de Tratamiento dPhase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSSquamous Cell Carcinoma of …The registry's MeSH filing›As of now · Rule based · Main conditionMain conditionDRUGSCetuximabIntervention entry›Nov 18 · Rule based · TestedTestedPaclitaxelIntervention entry›Nov 18 · Rule based · BackgroundBackgroundPembrolizumabIntervention entry›Nov 1 · Claude Opus 5.5 · Not givenNov 1 · Claude Opus 5.5 · Not givenNot given

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

All judgments on this study

WhenLinkJudgeDecisionState
Nov 1PembrolizumabClaude Opus 5.5Not givenReplaced
Nov 1PembrolizumabClaude Opus 5.5Not givenCurrent
Nov 18CetuximabRule based · role ruleTestedCurrent
Nov 18PaclitaxelRule based · role ruleBackgroundCurrent
As of nowSquamous Cell Carcinoma of Head and NeckRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.